Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
Clinical trial NCT07323095 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07323095
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-10-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.